PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAlbumin
Albumin human
Optison (albumin human) is a protein pharmaceutical. Albumin human was first approved as Optison on 1997-12-31.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
albumin (human)Biologic Licensing Application2010-01-07
albumin (human) 20%Biologic Licensing Application2009-12-16
albumin (human) 25%Biologic Licensing Application2009-12-22
albuminexBiologic Licensing Application2024-12-31
alburxBiologic Licensing Application2009-01-06
albuteinBiologic Licensing Application2008-07-01
beizrayNew Drug Application2024-11-04
definityNew Drug Application2024-03-13
definity rtNew Drug Application2024-03-13
draximage maaBiologic Licensing Application2024-02-13
Show 11 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08D: Ultrasound contrast media
— V08DA: Ultrasound contrast media
— V08DA01: Perflutren, human albumin microspheres
— V08DA04: Perflutren, phospholipid microspheres
HCPCS
No data
Clinical
Clinical Trials
168 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C505311514
Coronary artery diseaseD003324—I25.1211148
Heart diseasesD006331EFO_0003777I51.9223218
HypertensionD006973EFO_0000537I10——1236
Wounds and injuriesD014947—T14.81——135
Myocardial ischemiaD017202EFO_1001375I20-I25111125
Pulmonary hypertensionD006976EFO_0001361I27.201——124
Coronary diseaseD003327——111114
Cardiovascular diseasesD002318EFO_0000319I98———134
Myocardial perfusion imagingD055414——1—11—3
Show 14 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Retinal detachmentD012163EFO_0005773H33.2—12—710
Liver neoplasmsD008113EFO_1001513C22.0211—37
CarcinomaD002277—C80.0131—27
Hepatocellular carcinomaD006528—C22.0111—25
Prostatic neoplasmsD011471—C61112——4
Proliferative vitreoretinopathyD018630EFO_1001129——11——2
HemorrhageD006470MP_0001914R58—11—12
Liver diseasesD008107EFO_0001421K70-K77—11——2
Portal hypertensionD006975EFO_0000666K76.6——1—12
Macular degenerationD008268EFO_0001365H35.30—11——1
Show 6 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myocardial infarctionD009203EFO_0000612I21—2——68
FibrosisD005355——31——37
Cystic fibrosisD003550EFO_0000390E8441——27
InfarctionD007238EFO_0009463——2——57
Renal cell carcinomaD002292EFO_0000376—23——27
Dissociative disordersD004213—F44.1—1——56
Kidney diseasesD007674EFO_0003086N08—4——26
Chronic renal insufficiencyD051436—N18—4——15
St elevation myocardial infarctionD000072657———2——24
StrokeD020521EFO_0000712I63.922——24
Show 25 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lung diseasesD008171EFO_0003818J98.42———13
MelanomaD008545——1———12
Lung neoplasmsD008175—C34.902————2
Pulmonary fibrosisD011658—J84.101———12
Pulmonary embolismD011655EFO_0003827I261————1
EmbolismD004617——1————1
Obstructive sleep apneaD020181EFO_0003918G47.331————1
Lung transplantationD016040——1————1
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.91————1
EmphysemaD004646EFO_0000464J431————1
Show 19 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Retinal perforationsD012167EFO_1001028—————55
Diabetes mellitusD003920EFO_0000400E08-E13————44
Chest painD002637—R07.9————22
Type 2 diabetes mellitusD003924EFO_0001360E11————22
ProteinuriaD011507—R80————22
InflammationD007249MP_0001845—————22
Alzheimer diseaseD000544EFO_0000249F03————22
Inferior wall myocardial infarctionD056989EFO_1000983—————22
EndoleakD057867——————22
Acute kidney injuryD058186—N17————22
Show 66 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAlbumin human
INNperflutren
Description
Octafluoropropane is a fluorocarbon that is propane in which all of the hydrogens have been replaced by fluorines. It is a fluorocarbon and a fluoroalkane. It derives from a hydride of a propane.
Classification
Protein
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL1201451
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDCK0N3WH0SR (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,293 documents
View more details
Safety
Black-box Warning
Black-box warning for: Beizray, Definity, Definity rt, Optison, Paclitaxel, Paclitaxel protein bound particles albumin bound, Paclitaxel protein-bound particles for injectable suspension (albumin-bound), Sterile diluent for allergenic extract
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
4,837 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use